Evidence map›Paper›PMID 31101753›Full record

ArticleHaematologica2020

Validation of a

Amani Al Outa, Dana Abubaker, Ali Bazarbachi, Marwan El Sabban, Margret Shirinian, Rihab Nasr

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amani Al OutaDepartment of Anatomy, Cell Biology and Physiology, Faculty of Medicine, American University of Beirut.
Dana AbubakerDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut.
Ali BazarbachiDepartment of Anatomy, Cell Biology and Physiology, Faculty of Medicine, American University of Beirut.
Marwan El SabbanDepartment of Anatomy, Cell Biology and Physiology, Faculty of Medicine, American University of Beirut.
Margret ShirinianDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut ms241@aub.edu.lb.
Rihab NasrDepartment of Anatomy, Cell Biology and Physiology, Faculty of Medicine, American University of Beirut ms241@aub.edu.lb.
American University of Beirut · LB

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
NIH HHS P40 OD018537
6 · The paper itself

Abstract

Chronic myeloid leukemia is caused by a balanced chromosomal translocation resulting in the formation of

Indexed as

DrosophilaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnimalsDrosophila melanogasterDrug Resistance, NeoplasmFusion Proteins, bcr-ablProtein Kinase InhibitorsFusion Proteins, bcr-ablProtein Kinase Inhibitors

Identifiers

PMID31101753
PMCPMC7012492
OpenAlexW2945756920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.